263 related articles for article (PubMed ID: 21133648)
21. Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1).
Wu FY; Wang SE; Tang QQ; Fujimuro M; Chiou CJ; Zheng Q; Chen H; Hayward SD; Lane MD; Hayward GS
J Virol; 2003 Aug; 77(16):8893-914. PubMed ID: 12885907
[TBL] [Abstract][Full Text] [Related]
22. Effects of ER stress on unfolded protein responses, cell survival, and viral replication in primary effusion lymphoma.
Shigemi Z; Baba Y; Hara N; Matsuhiro J; Kagawa H; Watanabe T; Fujimuro M
Biochem Biophys Res Commun; 2016 Jan; 469(3):565-72. PubMed ID: 26692493
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression.
Schmidt K; Wies E; Neipel F
J Virol; 2011 May; 85(9):4530-7. PubMed ID: 21345951
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus.
Seo T; Park J; Lim C; Choe J
Oncogene; 2004 Aug; 23(36):6146-55. PubMed ID: 15208654
[TBL] [Abstract][Full Text] [Related]
25. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7.
Lubyova B; Kellum MJ; Frisancho AJ; Pitha PM
J Biol Chem; 2004 Feb; 279(9):7643-54. PubMed ID: 14668346
[TBL] [Abstract][Full Text] [Related]
27. Caspase-Dependent Suppression of Type I Interferon Signaling Promotes Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Tabtieng T; Degterev A; Gaglia MM
J Virol; 2018 May; 92(10):. PubMed ID: 29514903
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
[TBL] [Abstract][Full Text] [Related]
29. NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency.
Ma Z; Hopcraft SE; Yang F; Petrucelli A; Guo H; Ting JP; Dittmer DP; Damania B
PLoS Pathog; 2017 May; 13(5):e1006350. PubMed ID: 28459883
[TBL] [Abstract][Full Text] [Related]
30. Modulation of Cellular CpG DNA Methylation by Kaposi's Sarcoma-Associated Herpesvirus.
Journo G; Tushinsky C; Shterngas A; Avital N; Eran Y; Karpuj MV; Frenkel-Morgenstern M; Shamay M
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899086
[TBL] [Abstract][Full Text] [Related]
31. 1, 25(OH)2 D3 Induces Reactivation and Death of Kaposi's Sarcoma-Associated Herpesvirus of Primary Effusion Lymphoma cells.
Kumar A; Mohanty S; Das P; Sahu SK; Rajasubramaniam S; Choudhuri T
Sci Rep; 2017 Sep; 7(1):12438. PubMed ID: 28963501
[TBL] [Abstract][Full Text] [Related]
32. Immune evasion by Kaposi's sarcoma-associated herpesvirus.
Lee HR; Lee S; Chaudhary PM; Gill P; Jung JU
Future Microbiol; 2010 Sep; 5(9):1349-65. PubMed ID: 20860481
[TBL] [Abstract][Full Text] [Related]
33. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway.
Jacobs SR; Stopford CM; West JA; Bennett CL; Giffin L; Damania B
J Virol; 2015 Nov; 89(22):11572-83. PubMed ID: 26355087
[TBL] [Abstract][Full Text] [Related]
36. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
[TBL] [Abstract][Full Text] [Related]
37. Expression of Kaposi's sarcoma-associated herpesvirus-encoded K10/10.1 protein in tissues and its interaction with poly(A)-binding protein.
Kanno T; Sato Y; Sata T; Katano H
Virology; 2006 Aug; 352(1):100-9. PubMed ID: 16716377
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma.
Cao Y; Qiao J; Lin Z; Zabaleta J; Dai L; Qin Z
Oncotarget; 2017 Feb; 8(9):15220-15229. PubMed ID: 28146424
[TBL] [Abstract][Full Text] [Related]
39. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
[TBL] [Abstract][Full Text] [Related]
40. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.
Lefort S; Soucy-Faulkner A; Grandvaux N; Flamand L
J Virol; 2007 Oct; 81(20):10950-60. PubMed ID: 17652396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
